Effects of a Comprehensive Health Coaching Program in Advanced Chronic Obstructive Pulmonary Disease.

Effects of a Comprehensive Health Coaching Program on Lung Function, Exercise Tolerance, Symptom Distress, Quality of Life, Readmission, and Survival in Advanced Chronic Obstructive Pulmonary Disease Patients: A Randomized Controlled Trial.

Chronic obstructive pulmonary disease due to incurable and prevalence has increased steadily, chronic respiratory disease is considered hazardous to health and quality of life of the disease. GOLD treatment guidelines (global initiative for chronic obstructive lung disease guideline) pointed out the pulmonary rehabilitation is one of the non-drug treatment in patients with severe COPD, shown to improve exercise capacity and reduce the short of breathing, improve the quality of life and reduce the anxiety associated and depression and improved survival advantages. Meanwhile, a few studies have examined effect the exercise training in severe COPD patients' symptom distress and quality of life, so as to make severe COPD patients to improve the effectiveness of the campaign to ongoing regular pulmonary rehabilitation movement, is considered an important issue.

It has been proposed that physical activity enhancement or exercise training can be effective in improving symptoms and quality of life in these patients. However, it has not been examined systematically. Therefore, the main purposes of this study are: 1.Prevalence of symptom distress; 2.The physical preferences; 3.The relationship between quality of life and physical activity; 4.Effects of Comprehensive Health coaching exercise training on improving fatigue, sleep disturbances, quality of life, readmission, and survival. In the first year of this study, a descriptive-correlational design will be used and in the second and third years of study, the experimental design and prospective longitudinal study will be undertaken. Instruments include motion sensors, physical activity scale, Physical Activity Preferences, Pittsburgh Sleep Quality of Life Index. Statistical analyses include descriptive statistics, t-test, one-way ANOVA, latent growth modeling, Logistic models, GEE, and survival analysis. Results from this study will provide important implications for improving symptom management and quality of life for sever chronic obstructive pulmonary disease patients.

Study Overview

• Status: Unknown
• Conditions: Chronic Obstructive Pulmonary Disease Severe; Chronic Obstructive Pulmonary Disease End Stage
• Intervention / Treatment: Behavioral: Comprehensive Health Coaching Program

• Study Type: Interventional
• Enrollment (Anticipated): 50
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Taiwan
  • Taipei, Taiwan
    • Recruiting
    • Taipei Medical Hospital-Shuang Ho Hospital,Ministry of Health and Welfare

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 40 years to 80 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• age ≥40 years and ≦80 years
• patients with advanced COPD are defined according to the diagnostic criteria for severe (GOLD 3) and very severe (GOLD 4)
• pulmonologist assess need pulmonary rehabilitation, but not accept any rehabilitation exercise program.
• pulmonologist assessment the patients with a stable state.
• awareness, has the ability to read, write, and communication.
• willing to communicate by phone, and can operate smart phones.

Exclusion Criteria:

• COPD AE requiring corticosteroids, antibiotics, emergency room visit or hospitalization within the past 3 month.
• diagnosed mentally or cognitive disorder, such as dementia or unable to cooperate.
• severe hip, knee disease, can not perform exercise, or with neuromuscular dysfunction, such as limb hemiplegia, no independent walking function or other deterioration due to bone and joint disease.
• combined with severe heart disease, such as AMI, severe arrhythmia or heart failure.
• current regular practice of physical activity

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Supportive Care
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Experiment; Comprehensive Health Coaching Program	Behavioral: Comprehensive Health Coaching Program; Comprehensive Health Coaching Program: included physical activity and motivational interviewing techniques, participants were encouraged to set goals with decision-making, self-management and self-monitor their progress, and received support from researcher.
No Intervention: Control; Guideline-based usual care

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change from Baseline Lung function at 3 months, 6months	Spirometry (FEVl % predicted )	3 months, 6months
Change from Baseline Exercise Tolerance at 3 months, 6months	6 Minute walking test	3 months, 6months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change from Baseline Health-related quality of life at 3 months, 6months	St. George's Respiratory Questionnaire	3 months, 6months
Change from Baseline Fatigue at 3 months, 6months	Brief Fatigue Inventory Short Form BFI-Taiwan Form	3 months, 6months
Change from Baseline Psychological distress at 3 months, 6months	Hospital Anxiety and Depression Scale	3 months, 6months
Change from Baseline Symptom Distress at 3 months, 6months	Taiwanese version of the M. D. Anderson Symptom Inventory	3 months, 6months
Change from Baseline Quality of Sleep at 3 months, 6months	Taiwanese version of the Pittsburgh Sleep Quality Index	3 months, 6months
Readmission rate Survival	pulmonologists blinded to allocation reviewed admission summaries and information to determine as COPD related readmission or mortality	1 year

Collaborators and Investigators

• Sponsor: Taipei Medical University

Study record dates

Study Major Dates

• Study Start (Actual): March 1, 2018
• Primary Completion (Anticipated): July 31, 2020
• Study Completion (Anticipated): July 31, 2020

Study Registration Dates

• First Submitted: January 2, 2018
• First Submitted That Met QC Criteria: January 6, 2018
• First Posted (Actual): January 12, 2018

Study Record Updates

• Last Update Posted (Actual): April 26, 2018
• Last Update Submitted That Met QC Criteria: April 24, 2018
• Last Verified: November 1, 2017

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Obstructive; Pulmonary Disease, Chronic Obstructive
• Other Study ID Numbers: N201704032

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No